Biocatalysts is a speciality enzyme development and manufacturing company based in the UK, with an American subsidiary (Biocatalysts Inc), producing a wide range of products for the food and other industries.The company differentiates itself on its many unique products, technical capabilities, extensive knowledge of its key markets and the long term strategic relationships it has with its customers. Biocatalysts is an ambitious company employing bright committed individuals who are integral to the company achieving its long term goals.

Company HistoryBiocatalysts is a long established,

profitable, privately owned company

enjoying great relationships with its

stakeholders. It started life as a small

start-up and is now operating in purpose

built facilities just north of Cardiff in

Wales (UK). It is not a university spin

off company but enjoys strategic

relationships with many academic

institutions both in the United Kingdom

and globally.

The company was established in Wales in

the late eighties, started exporting in the early

1990s and is now a truly global company doing

business in 82 countries. Biocatalysts Inc was

incorporated in 2011, in Illinois USA, to further

develop the American market that has been so

fundamental to the growth of Biocatalysts over

the years. Having a dedicated team serving this

important market has made a huge difference

to the profile of Biocatalysts in the USA.

Other markets are supported either direct or

through a network of agents, the details of

which can be found at www.biocatalysts.com.

The company has enjoyed a stable history

with sustained growth year-on-year. It has

made considerable ongoing investments

in manufacturing plant, staff and laboratory

equipment, as well as always enjoying a sound

finance/investment strategy.

In 2004, the company relocated to a purpose

built facility with state-of-the-art laboratory and

production facilities with financial assistance

from the Welsh Government.

03

Our VisionWe will become and stay the world’s leading speciality enzyme development and manufacturing company and, by the quality and dedication of our people, exceed our customers’ expectations.

Enzymes can... surprise and delight, not a

traditional solution but an under-utilised one.

The breadth and depth of their applications

is not yet widely understood by many. Our

dedicated team of researchers, make it their

mission to understand and exploit everything

that these natural catalysts have to offer.

Enzymes do… the work of a small factory,

catalysing reactions to produce many

outcomes including functional and commercial.

Enzymes will… in the future be designed

intelligently, to deliver the optimal solution for

a process faster and more cost effectively

than is currently possible. The time to produce

small samples of unique enzymes will be short,

allowing customers to speed up new product

development. The use of enzymes will be far

more wide spread and consumers will be more

aware of the role they play in everyday life.

1. CompanyPhilosophyBiocatalysts was set up with customer service at its heart. The founding philosophy of the company was to make what the customer wants, not what production makes. This was a revolutionary approach in the 1980s and one that endeared us to many

customers, most of whom are still with the company today.

To achieve this philosophy, the company had to know what the customer wants. When the

company was founded in the mid eighties it was a new player in a mature market. Hence it

had to offer something new and better compared to that supplied by the competition. The

joint offering of custom tailored or novel enzyme development and exceptional customer

service were the differentiators giving Biocatalysts considerable competitive advantage.

Innovation has always been a major driver of the company, whether we achieve it by

adding new technical capabilities to benefit our customers, or implementing a suggestion

from a member of staff to improve a process or increase efficiency.

2.Boardof DirectorsBiocatalysts is a privately owned company

with a small board of directors chaired by

Dr Hans Wernicke, ex Sud-Chemie board

representative. Sud Chemie AG was

purchased by Clariant (a global speciality

chemical company) early in 2012.

Managing Director Stuart West has day

to day responsibility for the running of

the company.

He is an active member of the

KnowledgeTransfer Network’s

Biosciences (IB group). He is also a

campaigner to improve the skill levels

of scientists coming out of British

Universities and was on the SEMTA

Bioscience Sector Strategy Group (SSG)

and is now part of the Cogent SSG. He is

also a member of the CBI’s SME council

and the Institute of Directors (IOD).

Stuart West,

Managing Director

Dr Hans Wernicke, Chairman

05

3.Company CultureThe company has a strong culture which reflects the commitment and personalities of the stakeholders. Biocatalysts’ employees are recruited as

much for behaviours as for knowledge.

These performance driven employees

are empowered to make decisions and

recommend changes because they are all

aware of the company’s objectives.

Biocatalysts’ employees are enthusiastic

about the freedom they are given to meet

a challenge, solve a problem or develop

an idea. We actively encourage personal

development and growth, and opportunity is

wide open for people to develop in line with

the company’s long term vision.

Biocatalysts is a company that truly values

its employees and their commitment to

the company is demonstrated by their

low absenteeism and high take up rate of

development opportunities.

07

Stabilityinacyclicalworld….Due to the global nature of the business, there is always an economic downturn somewhere, where financial commitment to improving processes or developing new products comes second to “just surviving” in difficult times.During these times, Biocatalysts focuses on working with our customers so that when the

upturn comes, they are primed and ready to reap the rewards. Our team of development

scientists work with customers on a wide range of projects, from developing totally novel

new enzymes for new products that have never been commercially produced at all, to

solving a problem at just one stage of a 10 stage biocatalysis reaction that may have

brought a project to a complete halt.

We are able to do this in times of global recession because our focus on operating

strategy and financial stability means that we are able to look to the longer term and enjoy

supporting our customers through these difficult times. We are a company geared for

growth, constantly looking to reduce the time to market for new products (our own and

our customers’) whilst constantly improving our cost efficiencies internally.

“The companies that survive the

longest are the ones that work out

what they can uniquely give to the

world. Not just growth or money,

but their excellence, their respect for

others and their ability to make people

happy.” Charles Handy

4.TheEnzymeBlackBoxUsed to produce small samples of enzymes appropriate for our customers’ requirements, the Biocatalysts Black Box approach is a novel and exciting way of giving customers a unique solution which outputs a small sample of enzyme that is suitable for testing.

The whole process can currently be carried

out in a few weeks, which is many times

faster than other sources.

Introduction of new technology means that in

the future these times will reduce even further

and we will become the fastest enzyme

company in the world, able to deliver small

quantities of a completely novel enzyme by

intra or extracellular production.

5.CommercialisationThroughout the above process, the focus is on scalability and ensuring the process can be easily and reproducibly performed at industrially relevant scales.

This commercial focus is different to the

services provided by other organisations.

The speed with which this service can be

carried out can reduce the time to market

for our customers, and very often helps

them to launch new products earlier

than expected.

In relation to our Novel Enzyme

Development Services, our clients cover a

hugely broad base from aromas/flavours to

mining! Irrespective of the end application,

we have the expertise to identify and

manufacture commercial quantities of

novel enzymes to deliver a wide range

of functional benefits from small sample

through to commercially viable, stable large

scale product that can be shipped globally.

09

7.OurInvestmentinInnovationAs a company based around knowledge and innovation, it is only appropriate that >8% of sales revenue is invested into the New Product Development team for R&D purposes.

This ensures that the department is well resourced

to allow us the flexibility to work on both market

and customer funded projects. Each scientist

has their specialism, but can also be deployed to

other areas if a project requires it, allowing us to

be fast and flexible in response to our customers’

needs. The majority of our customers are looking

for an enzyme solution, therefore our focus

on development and scale up to commercial

production, in addition to straight research, gives

us considerable competitive advantage.

6.OurInnovationInnovation is at the core of Biocatalysts. Our culture is based on quality, customer service, technical knowledge and a desire to make positive changes through innovation

Innovation underpins our growth at

Biocatalysts, allowing us to better

serve our customers and other

stakeholders. We actively celebrate

innovation.

All Biocatalysts staff make positive

contributions to the generation and

implementation of ideas linked to

our working environment, processes

and infrastructure, in addition to

stimulating ideas for new enzyme

products.

Many of our stakeholders also

contribute ideas.

Companies committed to ‘Open

Innovation’ are ideal partners for us

to showcase our skills in this area

as we truly believe in the merits of

collaborating in an open, honest

and mutually beneficial manner.

We proactively identify, and bring

into the company, cutting edge

technology that will change the way

that the enzyme industry develops in

the future and offers our customers

unique enzymes at very reasonable

commercial costs.

Customers that share information and

actively involve us as a “partner of choice”

get the best from us, as we share our

enzyme knowledge to achieve the best

outcome. In addition to high profile food

industry customers, we also work with

many of the large API/healthcare/

chemical companies.

118.OurCustomersWe work best on a collaborative basis with our customers. The level of technical knowledge that our customers have varies hugely, so a key part of our role is working with them at a meaningful level.

WeholdthefollowingAccreditations Environmental Management - ISO 14001:2004

Quality Management - ISO 9001:2008

Occupational Health and Safety – OHSAS18001:2007

Food Safety – ISO 22000:2005

Additionally, we have HACCP and Good

Manufacturing Practice (GMP) accreditation.

HACCP is a system that identifies, evaluates

and controls hazards which are significant

for food safety. It was initially developed by

NASA to ensure food safety during space

travel and has since been adopted into the

Codex Guidelines.

Biocatalysts is an active member of AMFEP,

the umbrella organisation for manufacturers

of enzymes in Europe and which also has

affiliated members globally.

9.OurProcessesBiocatalysts has Environmental, Health & Safety (EHS) Management, Quality and comprehensive Food Safety systems in place. Production of safe compliant products is

fundamental to our reputation and in the

company’s entire history there has never

been a single issue with product safety,

a record that we are proud of, and intent

on maintaining.

Biocatalysts LimitedCefn Coed, Parc Nantgarw, Cardiff CF15 7QQ, Wales Phone: +44 (0) 1443 843 712 Fax: +44 (0) 1443 846 500 Email: sales@biocats.com customerservices@biocats.com

Biocatalysts Inc1241 Ellis Street, Bensenville, IL 60106, USA Toll free: 1-866-878-6914 Email: usa@biocats.com